+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiac POC Testing Devices - Global Market Trajectory & Analytics

  • ID: 5139739
  • Report
  • February 2022
  • Region: Global
  • 377 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Abbott Laboratories
  • BD Medical device company
  • Biomerica, Inc.
  • F. Hoffmann-La Roche AG
  • Medtronic plc
  • Nexus Dx, Inc.

Global Cardiac POC Testing Devices Market to Reach US$1.7 Billion by the Year 2026


Cardiac POC testing devices help in assessing cholesterol and blood glucose levels. Cardiac POC assay test kits deliver accurate results promptly and cost-effectively with standardization for minimizing operational errors. The POC cardiac marker market is a fast-growing segment of the overall global IVD industry. The increasing adoption of sensitivity and premium-priced POC Troponin tests is contributing to the growth of the global market. The growing move towards value-based and efficient healthcare service delivery against the backdrop of stringent budgets is boosting the prospects for POC Cardiac testing market. Moreover, the majority of medical professionals opt of POC cardiac testing to quickly monitor the condition of patients experiencing chest pain or other heart ailment symptoms in emergency care environments. The global phenomenon of the burgeoning aging populace is driving demand for POC test kits for use in home healthcare and old age homes. Growing patient awareness and the increasing availability of over the counter POC tests is a major factor propelling the POC tests market. At a time when the global healthcare industry is transitioning from disease treatment to disease prevention through increased involvement with patients, POC diagnostic kits are playing an instrumental role in reducing the risk of occurrence and the intensity of prevailing diseases by facilitating prompt diagnosis and earlier clinical intervention.

Amid the COVID-19 crisis, the global market for Cardiac POC Testing Devices estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2026, growing at a CAGR of 5.8% over the analysis period. Cardiac Markers Test, one of the segments analyzed in the report, is projected to grow at a 6.1% CAGR to reach US$1.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Analyzers segment is readjusted to a revised 5.1% CAGR for the next 7-year period. This segment currently accounts for a 29.7% share of the global Cardiac POC Testing Devices market. The blood cardiac biomarkers based evaluation of cardiac abnormalities is becoming more and more accurate, which is a major factor for the growing popularity of cardiac biomarkers. The increasing consumer awareness, coupled with growing adoption of cardiac kits, is set to drive the cardio biomarker market in the medium term.



The U.S. Market is Estimated at $500.5 Million in 2021, While China is Forecast to Reach $192.6 Million by 2026


The Cardiac POC Testing Devices market in the U.S. is estimated at US$500.5 Million in the year 2021. The country currently accounts for a 37.36% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$192.6 Million in the year 2026 trailing a CAGR of 7.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR while Rest of European market (as defined in the study) will reach US$204.7 Million by the end of the analysis period. The United States represents the largest market, driven by high prevalence of cardiovascular diseases, higher levels of physician and patient awareness, favorable government policies, and high usage of cardiac tests. The Asia Pacific region is also growing steadily on account of the increasing awareness about cardiac diagnosis and treatment as well as rising healthcare expenditure.

Select Competitors (Total 50 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Alfa Scientific Designs, Inc.
  • American Screening Corporation, Inc.
  • BD Medical device company
  • Beckman Coulter Inc.
  • Biomerica, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • LifeSign LLC
  • Medtronic plc
  • Nano-Ditech Corporation
  • Nexus Dx, Inc.
  • Nova Biomedical Corporation
  • PTS Diagnostics
  • Sekisui Medical Co., Ltd.
  • Siemens Healthineers AG
  • Werfen Life Group
Frequently Asked Questions about the Global Market for Cardiac POC Testing Devices

What is the estimated value of the Global Market for Cardiac POC Testing Devices?

The Global Market for Cardiac POC Testing Devices was estimated to be valued at $1.2 Billion in 2020.

What is the growth rate of the Global Market for Cardiac POC Testing Devices?

The growth rate of the Global Market for Cardiac POC Testing Devices is 6.0%, with an estimated value of $1.7 Billion by 2026.

What is the forecasted size of the Global Market for Cardiac POC Testing Devices?

The Global Market for Cardiac POC Testing Devices is estimated to be worth $1.7 Billion by 2026.

Who are the key companies in the Global Market for Cardiac POC Testing Devices?

Key companies in the Global Market for Cardiac POC Testing Devices include Abbott Laboratories, ACON Laboratories, Inc., Alfa Scientific Designs, Inc., American Screening Corporation, Inc., BD Medical device company, Beckman Coulter Inc., Biomerica, Inc., Bio and Danaher Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • BD Medical device company
  • Biomerica, Inc.
  • F. Hoffmann-La Roche AG
  • Medtronic plc
  • Nexus Dx, Inc.

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Cardiac POC Testing Devices - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • A Prelude to Cardiac POC Testing
  • Impact of Covid-19 and a Looming Global Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Impact of COVID-19 on Cardiac POCT Testing Market
  • Global Market Prospects and Outlook
  • Cardiac POC Testing Market Set to Record Strong Growth Led by Advancements in Cardiac Marker Testing
  • Cardiac Marker Tests Dominate the Cardiac POC Testing Market
  • North America Corners Major Share, Asia-Pacific to Record Fastest Growth
  • Competition
  • Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Rising Incidence, Mounting Economic and Social Burden of Cardiovascular Disease to Drive Market Growth
  • Leading Causes of Mortality Worldwide: Number of Deaths in Millions & % Share of Deaths by Cause for 2017
  • Leading Causes of Mortality for Low-Income and High-Income Countries
  • Aging Global Population at High Risk of Cardiac Illnesses Present Favorable Outlook for Cardiac POC Testing Devices
  • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
  • Technological Advances to Drive the Cardiac POC Diagnostics Market
  • An Overview of Available Quantitative and Qualitative POC Devices for Measuring Multiple Cardiac Markers
  • Increasing Demand for Troponin Tests Drive the Cardiac POC Market
  • Evolution of the Troponin Assay
  • Implementation of Unique & new Troponin-Based Tests Helps in Diagnosing MI
  • Optimizing Novel Troponin Assay Benefits
  • Troponin Applications: A Promising Future
  • Brain Natriuretic Peptide (BNP) Test Registers Significant Growth
  • Myoglobin Test
  • Myoglobin Test
  • Cardiac Biomarker Play Critical Role in Stroke Diagnosis

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)

CANADA

JAPAN

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)

CHINA

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)

EUROPE

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)

FRANCE

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

SPAIN


RUSSIA


REST OF EUROPE

ASIA-PACIFIC

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)

AUSTRALIA

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)

INDIA

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)

SOUTH KOREA


REST OF ASIA-PACIFIC

LATIN AMERICA

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)

ARGENTINA


BRAZIL


MEXICO


REST OF LATIN AMERICA

MIDDLE EAST

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)

IRAN


ISRAEL


SAUDI ARABIA


UNITED ARAB EMIRATES


REST OF MIDDLE EAST

AFRICA

  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)

IV. COMPETITION

  • Total Companies Profiled: 50
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Alfa Scientific Designs, Inc.
  • American Screening Corporation, Inc.
  • BD Medical device company
  • Beckman Coulter Inc.
  • Biomerica, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • LifeSign LLC
  • Medtronic plc
  • Nano-Ditech Corporation
  • Nexus Dx, Inc.
  • Nova Biomedical Corporation
  • PTS Diagnostics
  • Sekisui Medical Co., Ltd.
  • Siemens Healthineers AG
  • Werfen Life Group
Note: Product cover images may vary from those shown